1. Search Result
Search Result
Results for "

C20

" in MedChemExpress (MCE) Product Catalog:

38

Inhibitors & Agonists

3

Biochemical Assay Reagents

4

Peptides

5

Natural
Products

18

Recombinant Proteins

3

Isotope-Labeled Compounds

6

Antibodies

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-112016

    N-Arachidoyl-D-sphingosine

    Endogenous Metabolite Others
    C20 Ceramide is a natural 20:0 ceramide that is abundant in the brain .
    C20 Ceramide
  • HY-134104

    D-erythro-Sphingosine-C20

    Others Neurological Disease
    C20-Sphingosine is a long-chain base (LCB) that can be used in the study of neural development .
    C20-Sphingosine
  • HY-19796
    Icomidocholic acid
    1 Publications Verification

    Aramchol; C20-FABAC

    Stearoyl-CoA Desaturase (SCD) Metabolic Disease
    Icomidocholic acid (Aramchol) is a conjugate of cholic acid and arachidic acid that could inhibit stearoyl coenzyme A desaturase 1 (SCD1) activity. Icomidocholic acid has potential use in nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) treatment .
    Icomidocholic acid
  • HY-136190

    TRP Channel Neurological Disease
    TRPC6-PAM-C20 is a selective positive allosteric modulator (PAM) of TRPC6 channels. TRPC6-PAM-C20 is a potent enhancer of channel activation, enabling low basal concentrations of DAG to induce activation of the ion channel. TRPC6-PAM-C20 induces increases in intracellular Ca 2+ concentrations ([Ca 2+]i) in TRPC6-expressing HEK293 cells with an EC50 of 2.37 μM. TRPC6-PAM-C20 can be used as a valuable tool to selectively exaggerate TRPC6-dependent signals .
    TRPC6-PAM-C20
  • HY-W414466

    D-Erythro-sphinganine C20 chain

    Biochemical Assay Reagents Metabolic Disease
    C20-Dihydrosphingosine (D-Erythro-sphinganine C20 chain) is an ester product.
    C20-Dihydrosphingosine
  • HY-145549

    N-eicosanoyl-D-erythro-Sphingosylphosphorylcholine; SM(d18:1/20:0)

    Endogenous Metabolite Endocrinology
    C20 Sphingomyelin (d18:1/20:0) (N-eicosanoyl-D-erythro-Sphingosylphosphorylcholine; SM(d18:1/20:0)) is a naturally occurring sphingolipid. C20 Sphingomyelin (d18:1/20:0) levels are upregulated in the hippocampus of streptozotocin (HY-13753)-induced diabetic rats and in human plasma, positively correlating with insulin resistance in obese humans. C20 Sphingomyelin (d18:1/20:0) is also upregulated in the liver of a mouse model of Niemann-Pick C1 disease, a neurodegenerative cholesterol sphingolipid lysosomal storage disorder.
    C20 Sphingomyelin (d18:1/20:0)
  • HY-146935S

    Isotope-Labeled Compounds Others
    C20:1 Ceramide-d7 is deuterium labeled C20:1 Ceramide.
    C20:1 Ceramide-d7
  • HY-W590670

    N-[(2S,3R)-1,3-Dihydroxyoctadecan-2-yl]icosanamide

    Biochemical Assay Reagents Others
    C20-Dihydroceramide is a biochemical assay reagent.
    C20-Dihydroceramide
  • HY-158611

    C20:5 (cis-4,7,10,13,16) Methyl ester; SFE 20:5

    Biochemical Assay Reagents Others
    4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic acid methyl ester 是一种生化试剂。
    4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic acid methyl ester
  • HY-112016A

    SM C20:2

    Others Neurological Disease
    Sphingomyelin C20:2 (SM C20:2) is a sphingomyelin biomarker metabolite. Sphingomyelin C20:2 can be used in Alzheimer's disease (AD) research .
    Sphingomyelin C20:2
  • HY-164412

    Others Others
    Phosphatidylcholine (C18:2,C20:4) is a phospholipid that can be isolated from egg yolk .
    Phosphatidylcholine (C18:2,C20:4)
  • HY-W127624

    Polyoxyethylene Monocetyl Ether (n=approx. 23)

    Biochemical Assay Reagents Others
    Brij-C20 is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    Brij-C20
  • HY-N11436

    Others Others
    Aconicarchamine B is a C20-diterpenoid alkaloid, which can be isolated from Aconitum carmichaelii .
    Aconicarchamine B
  • HY-158790

    Ferroptosis Cancer
    (R)-HTS-3 is an lysophosphatidylcholine acyltransferase 3 (LPCAT3) inhibitor, with an IC50 of 0.09 μM. (R)-HTS-3 suppresses the C20:4 content of PE, PC, and PS, while promoting a correspondingelevation in C22:4 phospholipids and a paradoxical increase in C20:4 phosphatidylinositol (PI) lipids .
    (R)-HTS-3
  • HY-163635

    Fungal Infection
    Antifungal agent 102 (compound C20) is a antifungal agent aganist B. cinerea with the EC50 of 1.23 μg/mL .
    Antifungal agent 102
  • HY-W127464

    Biochemical Assay Reagents Others
    Arachidyl Laurate is a laurate medium chain saturated (C20:0) fatty acid ester compound that can be used as a reference for the analysis of wax laurate.
    Arachidyl Laurate
  • HY-153203

    20:5 Coenzyme A triammonium

    Others Others
    Eicosapentaenoyl-CoA triammonium (C20:5-CoA) is an unsaturated fatty acyl-CoA that can assist in the measurement of enzymatic activity of the TrWSD4 enzyme .
    Eicosapentaenoyl-CoA triammonium
  • HY-W718405

    Endogenous Metabolite Others
    (5Z,14Z)-5,14-Eicosadienoic acid is a ω-6 C20:2 fatty acid .
    (5Z,14Z)-5,14-Eicosadienoic acid
  • HY-114668

    Camptothecin-20-O-propionate

    Topoisomerase Cancer
    Camptothecin-20(S)-O-propionate (CZ48), the C20-propionate ester of CPT, is a highly effective anticancer agent. Camptothecin-20(S)-O-propionate (CZ48) is a topoisomerase-Ι inhibitor .
    Camptothecin-20(S)-O-propionate
  • HY-114668A

    Camptothecin-20-O-propionate hydrate

    Topoisomerase Cancer
    Camptothecin-20(S)-O-propionate (Camptothecin-20-O-propionate) hydrate, the C20-propionate ester of CPT, is a highly effective anticancer agent. Camptothecin-20(S)-O-propionate hydrate is a topoisomerase-Ι inhibitor .
    Camptothecin-20(S)-O-propionate hydrate
  • HY-118274

    GC 300

    Others Others
    ADDA (GC 300) is a unique C20 amino acid that is a key component of hepatotoxins produced by cyanobacteria. ADDA is essential for the toxicity of nodularin and microcystin, toxins that can cause liver damage. ADDA can be used for research in toxicology .
    ADDA
  • HY-149985

    Parasite Infection
    Antitrypanosomal agent 12 is a C20-phenylthiourea with trypanocidal and cytotoxic activities. Antitrypanosomal agent 12 shows antitrypanosomal activity with 50% growth inhibition (GI50) values of 0.22 μM. Antitrypanosomal agent 12 induces faster cell swelling in bloodstream-form trypanosomes than Salinomycin (HY-15597) .
    Antitrypanosomal agent 12
  • HY-116620

    Neurokinin Receptor Infection
    Benzomalvin C is a weak antagonist of the neurokinin-1 (NK1) receptor inhibiting binding of substance P by 46% when used at 100 μg/mL in vitro. It is also a weak inhibitor of indolamine 2,3-dioxygenase (IDO) with an IC50 value of 130 μM for recombinant IDO. It is isolated from Penicillium and contains an epoxide group at C-19 and C-20, which is not present in benzomalvins A, B, or E.
    Benzomalvin C
  • HY-149526

    Cyclic GMP-AMP Synthase Inflammation/Immunology
    cGAS-IN-1 (compound C20) is a flavonoid and Cyclic GMP-AMP Synthase (cGAS) inhibitor with IC50s of 2.28 μM (human cGAS) and 1.44 μM (mouse cGAS). Abnormal activation of cGAS is associated with a variety of immune-mediated inflammatory diseases, and cGAS-IN-1 has potential anti-inflammatory activity .
    cGAS-IN-1
  • HY-113445

    COX Endogenous Metabolite Endocrinology
    Thromboxane B3 is a prostaglandin analog derived from arachidonic acid (AA) in the cyclooxygenase (COX) metabolic pathway. Thromboxane B3 is generated from arachidonic acid (AA) in platelets and vascular endothelial cells through the catalysis of cyclooxygenase (COX) and thromboxane synthase (TXS). Thromboxane B3 has been reported to be formed by human platelets upon ingestion of eicosapentaenoic acid (C20: 5ω3) .
    Thromboxane B3
  • HY-N10703

    Others Others
    2-Isopropyl-8,8-dimethyl-7,8-dihydrophenanthrene-3,4,5(6H)-trione is a C20 -norabietane diterpenoid with anti-inflammatory activity. 2-Isopropyl-8,8-dimethyl-7,8-dihydrophenanthrene-3,4,5(6H)-trione can be isolated from sage leaves .
    1-Oxomiltirone
  • HY-151595

    Epigenetic Reader Domain Cancer
    Menin-MLL inhibitor-22 (compound C20) is an orally active inhibitor of the interaction between menin and mixed lineage leukemia (MLL) (IC50=7 nM). Menin-MLL inhibitor-22 binds menin protein and inhibits cancer cell growth (MV4 cells, IC50=0.3 μM). Menin is a putative tumor suppressor associated with multiple endocrine neoplasia type 1 (MEN-1 syndrome) .
    Menin-MLL inhibitor-22
  • HY-138889

    Endogenous Metabolite Metabolic Disease
    8(Z),14(Z)-Eicosadienoic Acid is an ω-8 C20:2 fatty acid. The presence of 8(Z),14(Z)-eicosadienoic acid has been detected in human milk at a level of 0.19% (weight % total fatty acids).1 Eicosadienoic acids are converted by desaturases, in vivo, to eicosatrienoic acids, which are potent vasodilators. The physiological effects of 8(Z),14(Z)-eicosadienoic acid are unstudied.
    (8Z,14Z)-Eicosadienoic acid
  • HY-141635

    Endogenous Metabolite Metabolic Disease
    cis-11,14-Eicosadienoic acid methyl ester is a more lipid soluble form of the ω-6 C20-2 fatty acid 11(Z),14(Z)-eicosadienoic acid, a naturally occurring PUFA. 11(Z),14(Z)-Eicosadienoic acid competitively inhibits inosine 5’-monophosphate dehydrogenase (Ki=3.1 μM) and inhibits the binding of LTB4 to its receptor on neutrophils (Ki=3.0 μM). Also, serum levels of eicosadienoic acids negatively correlate with degree of sleep disturbance.3 Eicosadienoic acids are converted by desaturases, in vivo, to eicosatrienoic acids, which are potent vasodilators.
    cis-11,14-Eicosadienoic acid methyl ester
  • HY-139062

    C6 Ceramide (d18:1/6:0) Urea; Cer(d18:1/6:0) Urea; D-erythro-Urea-C6-Ceramide

    Apoptosis Ceramidase Autophagy β-catenin Cancer
    C6 Urea Ceramide (Cer(d18:1/6:0) Urea) is an inhibitor of neutral ceramidase. C6 Urea Ceramide increases total ceramide levels in wild-type mouse embryonic fibroblasts (MEFs) and HT-29 colon cancer cells. C6 Urea Ceramide (5-10 μM) inhibits proliferation of HT-29 cells and induces apoptosis and autophagy, but is not toxic to non-cancerous cells. C6 Urea Ceramide decreases total and phosphorylated β-catenin levels in HT-29 and HCT116 cells, and induces colocalization of β-catenin with the 20S proteasome. C6 Urea Ceramide (1.25, 2.5, and 5 mg/kg) reduced tumor growth and increased C16, C18, C20, and C24 ceramide levels in tumor tissues in the HT-29 mouse xenograft model.
    C6 Urea Ceramide
  • HY-N6786S

    Isotope-Labeled Compounds Cancer
    Ochratoxin B- 13C20 is 13C-labeled Ochratoxin B (HY-N6786). Ochratoxin B, a secondary metabolite of Aspergillus ochraceus, is the nonchlorinated analogue of the mycotoxin Ochratoxin A. Ochratoxin B has been shown to reduce the toxic effects of Ochratoxin A, and it is one of the most potent renal carcinogens in rodents .
    Ochratoxin B-13C20
  • HY-169964

    Carbonic Anhydrase Neurological Disease
    TSPO/Carbonic Anhydrase Modulator 1 (Compound 3) is a dual modulator for mitochondrial translocator protein and Carbonic Anhydrase with a Ki of 1.340 μM for TSPO and a KA of 10.7 μM for CA VII. TSPO/Carbonic Anhydrase Modulator 1 promotes the production of neurosteroid, increases BDNF gene expression, exhibits neuroprotective efficacy .
    TSPO/Carbonic Anhydrase Modulator 1
  • HY-P3506
    Retatrutide
    1 Publications Verification

    LY3437943

    GCGR GLP Receptor Metabolic Disease
    Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide binds human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide can be used for the research of obesity .
    Retatrutide
  • HY-P3506A
    Retatrutide TFA
    1 Publications Verification

    LY3437943 TFA

    GLP Receptor GCGR Metabolic Disease
    Retatrutide (LY3437943) TFA is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide TFA binds human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide TFA can be used for the research of obesity .
    Retatrutide TFA
  • HY-P10591

    Olatorepatidum

    Insulin Receptor GLP Receptor Metabolic Disease
    Olatorepatide (Olatorepatidum) is a dual gastric inhibitory polypeptide (GIP) receptor and glucagon like peptide 1 (GLP-1) receptor agonist, with antidiabetic effect .
    Olatorepatide
  • HY-P10798

    LY-3841136

    Amylin Receptor Metabolic Disease
    Eloralintide (LY 3841136) is an AMYR agonist, which is promising for research of type 2 diabetes and obesity .
    Eloralintide
  • HY-110382S

    13C20,15N10-c-di-GMP, 13C20,15N10-Cyclic diguaylate, 13C20,15N10-3’,5’-Cyclic diguaylic Acid

    Isotope-Labeled Compounds Endogenous Metabolite STING Cancer
    13C20, 15N10-Cyclic di-GMP ( 13C20, 15N10-c-di-GMP) is 13C and 15N labeled Cyclic-di-GMP (disodium). Cyclic-di-GMP disodium is a STING agonist and a bacterial second messenger that coordinates different aspects of bacterial growth and behavior, including motility, virulence, biofilm formation, and cell cycle progression. Cyclic-di-GMP disodium has anti-cancer cell proliferation activity and also induces elevated CD4 receptor expression and cell cycle arrest. Cyclic-di-GMP disodium can be used in cancer research .
    13C20,15N10-Cyclic di-GMP sodium
  • HY-156991

    NODA-GA-NHS ester

    Radionuclide-Drug Conjugates (RDCs) EGFR Cancer
    NODAGA-NHS (NODA-GA-NHS ester) is a [64]Cu chelator and the dissociated form of DOTA-trastuzumab in vivo. NODAGA-NHS was added in 0.1 M borate buffer at a ratio of 5/20/100 and was able to effectively bind trastuzumab (10 mg/mL) (4°C, 20 h). The copper content of the [64]Cu-NODAGA-trastuzumab was up to 80%. After blood was drawn from the caudal vein of mice, [64]Cu-NODAGA-trastuzumab was injected and showed good tumor uptake in mice expressing HER2 tumors, showing good PET imaging tracking ability.
    NODAGA-NHS

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: